Biomarin Pharmaceutical Inc (BM8.DU)
Dusseldorf - Dusseldorf Delayed price. Currency in EUR
Add to watchlist
At close: 07:31PM CEST
| Previous close | 77.22 |
| Open | 78.02 |
| Bid | 76.80 x 0 |
| Ask | 76.98 x 0 |
| Day's range | 77.38 - 78.04 |
| 52-week range | 68.02 - 90.62 |
| Volume | |
| Avg. volume | 0 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Shares Could Be 41% Below Their Intrinsic Value Estimate
Key Insights BioMarin Pharmaceutical's estimated fair value is US$142 based on 2 Stage Free Cash Flow to Equity Current...
- Insider Monkey
Should You Hold BioMarin Pharmaceutical (BMRN) Despite Setback?
Scout Investments, Inc, an affiliate of Carillon Tower Advisers, released the “Carillon Scout Mid Cap Fund” first quarter 2024 investor letter. A copy of the letter can be downloaded here. In the first quarter, most indices generated significant gains driven by more cyclical industries including energy, financials, and industrials. The combination of a positive outlook for […]
- Zacks
Mirum Pharmaceuticals (MIRM) Soars 27.3%: Is Further Upside Left in the Stock?
Mirum Pharmaceuticals (MIRM) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
© 2024 Yahoo. All rights reserved.